Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management-Reference-Cited by-同舟云学术

Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management

Published:2000-05 Issue:5 Volume:40 Page:580-584
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kiely P.,Wilson D.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1537-2995.2000.40050580.x/fullpdf

Reference17 articles.

1. High proportion of false positive reactions among donors with anti-HCV antibodies in a low prevalence area

2. Hepatitis C-related chronic liver disease among asymptomatic blood donors in the North West of England

3. Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays

4. False Positive Tests for Anti-Hepatitis C Antibodies and the Problem of Notifying Blood Donors

5. Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HCV immunoblot indeterminate results in blood donors: non-specific reactivity or past exposure to HCV?;Vox Sanguinis;2017-08

2. Determining immunoassay cutoff value using Western blot results to predict hepatitis C infection in blood donors with low-titer anti-HCV reactivity;Folia Microbiologica;2012-12-04

3. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing;Transfusion Medicine;2010-06

4. Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion, AWMF-Register-Nr.: 021 / 012;Zeitschrift für Gastroenterologie;2010-01-29

5. An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories;Vox Sanguinis;2009-11